Home » Topics » Conferences

Conferences
RSS

ISTH news: antiplatelet/anticoagulant effects of PI-88 characterized

July 11, 2001

Antithrombin and antithrombotic effects of LB-30057 discussed at ISTH meeting

July 11, 2001

Novel anticoagulant targets surface-bound thrombin, may be preferable to heparin

July 11, 2001

Orally active gpIIb/IIIa antagonist shows broad-spectrum antiplatelet effects

July 11, 2001

Servier characterizes mixed TP/5-HT2A receptor antagonist at ISTH meeting

July 11, 2001

Pharmacological profile of dual TxA2 antagonist and Tx synthase inhibitor discussed at ISTH

July 10, 2001

NCX-4016 has distinct pharmacological properties from acetylsalicylic acid

July 10, 2001

Role for olanzapine in Alzheimer's disease patients with BPSD

July 10, 2001

ISTH news: promising new factor VIIa inhibitor synthesized at Ajinomoto

July 10, 2001

Mixed thrombin, factor Xa and platelet aggregation inhibition provided by BIBR-830ZW

July 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...